550 related articles for article (PubMed ID: 16569685)
1. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
4. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
7. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
8. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Jonsson R; Natvig JB; Thompson KM
Clin Immunol; 2002 Apr; 103(1):79-88. PubMed ID: 11987988
[TBL] [Abstract][Full Text] [Related]
9. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin free light chains in severe forms of atopic dermatitis.
Kayserova J; Capkova S; Skalicka A; Vernerova E; Polouckova A; Malinova V; Bartunkova J; Sediva A
Scand J Immunol; 2010 Apr; 71(4):312-6. PubMed ID: 20384876
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
12. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
13. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis.
Elkon KB; Gharavi AE; Patel BM; Hughes GR; Frankel A
Clin Exp Immunol; 1983 Apr; 52(1):75-84. PubMed ID: 6861373
[TBL] [Abstract][Full Text] [Related]
14. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
[TBL] [Abstract][Full Text] [Related]
16. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
Liu MF; Lin LH; Weng CT; Weng MY
Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H
Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712
[TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process.
Tzioufas AG; Costello R; Manoussakis MN; Papadopoulos NM; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():111-3. PubMed ID: 3109019
[TBL] [Abstract][Full Text] [Related]
19. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
Low JM; Chauhan AK; Moore TL
Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
[TBL] [Abstract][Full Text] [Related]
20. Immunohistologically definable light chain restriction in autoimmune disease.
Jasani B
J Pathol; 1988 Jan; 154(1):1-5. PubMed ID: 3126283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
